A pilot study for safety and efficacy of 12 weeks sofosbuvir plus daclatasvir with or without ribavirin in egyptian adolescents with chronic hepatitis C virus Infection
2001 ◽
Vol 8
(4)
◽
pp. 287-292
◽
2019 ◽
Vol 2
(7)
◽
pp. 03-07
◽
2010 ◽
Vol 105
◽
pp. S114
2018 ◽
Vol 11
(2)
◽
pp. 156-164
◽